1[1]Shapira Y,Herel S,Russell A,et al.Mitochondrialencephalopathy:a Group of neuromusculardisorders with defects in oxidative metabolism.Isr J Med Sei 1997;13:161 .
3[3]Goto Y,Nonaka I,Horai SA Mutation in the tRNAlelett(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.Nature 1990;348:651.
5[5]Hess J F,Parisi MA,Bennett J L,et al.Impairment of mitochondrial transcription termination by appoint mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies.Nature 1991;351:236.
6[6]Poulton J,Morten K.Noninvasive diagnosis of the MELAS syndrome from blood DNA.Ann Neurol 1993;34:116.
7[7]Suonalainen A,Majander A,Pinko H,et al.Quantificatio of tRNA lett(UUR) point mutatio of mitochondrial DNA in MELAS patients and its effects on mitochondrial transcription.Hum Mol Genet 1993;2:525.
8[8]Koga Y,Akita Y,Takane N,et al.Heterogeneous presentation in A3243G mutatio in the mitochondrial tRNAlett(UUR)gene.Arch Dis Child 2000;82:407.
10[10]Nariai T Ohno K,Akimoto H,etal.Cerebral blood flow vascular response and metabolism in patients with MELAS syndrome-xenon CT and PET study.Keio J Med 2000;49:S1 A 68.
